Evidence map›Paper›PMID 28452682›Full record

ArticleTissue barriers2017

Entamoeba histolytica: Host parasite interactions at the colonic epithelium.

Steve Cornick, Kris Chadee

Open access · bronzeAbstract read
In one paragraph

Article in Tissue barriers, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Intestinal Parasitic Infections in 2023.Gastroenterology research · 2023
    Review
  7. Article
  8. Diversity and Plasticity of Virulent Characteristics ofTropical medicine and infectious disease · 2023
    Review
  9. Article
  10. Article
  11. Review
  12. Tropical medicine and health · 2020
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Editorial: Recent Progresses in Amebiasis.Frontiers in cellular and infection microbiology · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Steve Cornicka Department of Microbiology, Immunology and Infectious Diseases , Snyder Institute for Chronic Diseases, University of Calgary , Calgary , Alberta , Canada.
Kris Chadeea Department of Microbiology, Immunology and Infectious Diseases , Snyder Institute for Chronic Diseases, University of Calgary , Calgary , Alberta , Canada.
University of Calgary · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Entamoeba histolytica (Eh) is the protozoan parasite responsible for intestinal amebiasis and interacts dynamically with the host intestinal epithelium during disease pathogenesis. A multifaceted pathogenesis profile accounts for why 90% of individuals infected with Eh are largely asymptomatic. For 100 millions individuals that are infected each year, key interactions within the intestinal mucosa dictate disease susceptibility. The ability for Eh to induce amebic colitis and disseminate into extraintestinal organs depends on the parasite competing with indigenous bacteria and overcoming the mucus barrier, binding to host cells inducing their cell death, invasion through the mucosa and outsmarting the immune system. In this review we summarize how Eh interacts with the intestinal epithelium and subverts host defense mechanisms in disease pathogenesis.

Indexed as

ColonEntamoeba histolyticaHost-Parasite InteractionsHumansIntestinal Mucosaantimicrobial peptidescysteine proteasesentamoeba histolyticaepitheliuminflammasomemucustight junction proteins

Identifiers

PMID28452682
PMCPMC5362996
OpenAlexW2575368573

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.